Altered Ca2+ dependence of synaptosomal plasma membrane Ca2+-ATPase in human brain affected by Alzheimer's disease.

No Thumbnail Available
Identifiers

Publication date

2009

Start date of the public exhibition period

End date of the public exhibition period

Authors

Berrocal, María
Sepúlveda, María Rosario
Pérez, Mar
Ávila, Jesús
Mata, Ana M.

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

The FASEB Journal
Metrics
Google Scholar

Research Projects

Organizational Units

Journal Issue

Abstract

High-affinity Ca2+ transport ATPases play a crucial role in controlling cytosolic Ca2+. The amyloid β-peptide (Aβ) is a neurotoxic agent found in affected neurons in Alzheimer's disease (AD) that has been implicated in dysregulation of Ca2+ homeostasis. Using kinetic assays, we have shown that the Ca2+ dependencies of intracellular Ca2+-ATPase (SERCA and SPCA) activity are the same in human AD and normal brain but that of plasma membrane Ca2+-ATPase (PMCA) is different. The addition of Aβ to normal brain decreases the PMCA activity measured at pCa 5.5, resulting in the same Ca2+ dependency as that seen in AD brain, whereas the addition of Aβ to AD brain has no effect on PMCA activity. Aβ also decreases the activity of PMCA purified from pig cerebrum, the effect being isoform specific. The level of inhibition of purified PMCA caused by Aβ is reduced by cholesterol, and the level of inhibition of PMCA activity by Aβ in the raft fraction of pig synaptosomal membranes is lower than for the nonraft fraction. We conclude that the effect of Aβ on PMCA activity could be important in amyloid toxicity, resulting in cytoplasmic Ca2+ dysregulation and could explain the different Ca2+ dependencies of PMCA activity observed in normal and AD brain.—Berrocal, M.,Marcos, D., Sepulveda, M.R., Perez, M., Avila, J., Mata, A.M. Altered Ca2+ dependence of synaptosomal plasma membrane Ca2+-ATPase in human brain affected by Alzheimer's disease. FASEB J. 23, 1826–1834 (2009)

Doctoral program

Description

Keywords

Citation